|
GILD
|
Gilead Sciences, Inc.
|
8.12%
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
7.78%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
7.33%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
6.91%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
6.43%
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
4.02%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
3.71%
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
2.95%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.57%
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
2.38%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
2.35%
|
US
|
NASDAQ
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.88%
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
1.67%
|
US
|
NASDAQ
|
|
RPRX
|
Royalty Pharma plc
|
1.56%
|
US
|
NASDAQ
|
|
VTRS
|
Viatris Inc.
|
1.36%
|
US
|
NASDAQ
|
|
SNY
|
Sanofi
|
1.29%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
1.28%
|
US
|
NASDAQ
|
|
UTHR
|
United Therapeutics Corporation
|
1.17%
|
US
|
NASDAQ
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
1.10%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
1.09%
|
US
|
NASDAQ
|